520 related articles for article (PubMed ID: 24347425)
1. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma.
van Berkel A; Lenders JW; Timmers HJ
Eur J Endocrinol; 2014 Mar; 170(3):R109-19. PubMed ID: 24347425
[TBL] [Abstract][Full Text] [Related]
2. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
[TBL] [Abstract][Full Text] [Related]
3. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT; Frystyk J; Poulsen PL
Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
[TBL] [Abstract][Full Text] [Related]
4. Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
Därr R; Pamporaki C; Peitzsch M; Miehle K; Prejbisz A; Peczkowska M; Weismann D; Beuschlein F; Sinnott R; Bornstein SR; Neumann HP; Januszewicz A; Lenders J; Eisenhofer G
Clin Endocrinol (Oxf); 2014 Apr; 80(4):478-86. PubMed ID: 24102244
[TBL] [Abstract][Full Text] [Related]
5. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
Eisenhofer G; Deutschbein T; Constantinescu G; Langton K; Pamporaki C; Calsina B; Monteagudo M; Peitzsch M; Fliedner S; Timmers HJLM; Bechmann N; Fankhauser M; Nölting S; Beuschlein F; Stell A; Fassnacht M; Prejbisz A; Lenders JWM; Robledo M
Clin Chem Lab Med; 2020 Oct; 59(2):353-363. PubMed ID: 33001846
[TBL] [Abstract][Full Text] [Related]
6. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
[TBL] [Abstract][Full Text] [Related]
7. Biochemical Assessment of Pheochromocytoma and Paraganglioma.
Eisenhofer G; Pamporaki C; Lenders JWM
Endocr Rev; 2023 Sep; 44(5):862-909. PubMed ID: 36996131
[TBL] [Abstract][Full Text] [Related]
8. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.
Peitzsch M; Prejbisz A; Kroiß M; Beuschlein F; Arlt W; Januszewicz A; Siegert G; Eisenhofer G
Ann Clin Biochem; 2013 Mar; 50(Pt 2):147-55. PubMed ID: 23512172
[TBL] [Abstract][Full Text] [Related]
9. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.
Eisenhofer G; Lenders JW; Siegert G; Bornstein SR; Friberg P; Milosevic D; Mannelli M; Linehan WM; Adams K; Timmers HJ; Pacak K
Eur J Cancer; 2012 Jul; 48(11):1739-49. PubMed ID: 22036874
[TBL] [Abstract][Full Text] [Related]
10. Laboratory evaluation of pheochromocytoma and paraganglioma.
Eisenhofer G; Peitzsch M
Clin Chem; 2014 Dec; 60(12):1486-99. PubMed ID: 25332315
[TBL] [Abstract][Full Text] [Related]
11. Urinary clonidine suppression testing for the diagnosis of pheochromocytoma.
Goupil R; Fountoulakis S; Gordon RD; Stowasser M
J Hypertens; 2015 Nov; 33(11):2286-93. PubMed ID: 26335433
[TBL] [Abstract][Full Text] [Related]
12. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
[TBL] [Abstract][Full Text] [Related]
13. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
[TBL] [Abstract][Full Text] [Related]
14. Single-centre study of the diagnostic performance of plasma metanephrines with seated sampling for the diagnosis of phaeochromocytoma/paraganglioma.
Boot C; Toole B; Johnson SJ; Ball S; Neely D
Ann Clin Biochem; 2017 Jan; 54(1):143-148. PubMed ID: 27170024
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
[TBL] [Abstract][Full Text] [Related]
16. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
Eisenhofer G; Lenders JW; Goldstein DS; Mannelli M; Csako G; Walther MM; Brouwers FM; Pacak K
Clin Chem; 2005 Apr; 51(4):735-44. PubMed ID: 15718487
[TBL] [Abstract][Full Text] [Related]
17. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
[TBL] [Abstract][Full Text] [Related]
18. Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma.
Wang K; Gao X; Zhang W; Sun N; Xie L; Cong H; Guo Y; Shi X; Zhou Z
Scand J Clin Lab Invest; 2021 Nov; 81(7):564-572. PubMed ID: 34570657
[TBL] [Abstract][Full Text] [Related]
19. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.
Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
[TBL] [Abstract][Full Text] [Related]
20. Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias.
Martínez-Morillo E; Valdés Gallego N; Eguia Ángeles E; Fernández Fernández JC; Prieto García B; Álvarez FV
Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):312-319. PubMed ID: 30391255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
